These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 32358683)

  • 1. Population pharmacokinetics of gentamicin in haemodialysis patients: modelling, simulations and recommendations.
    Franck B; Monchaud C; Saint-Marcoux F; Rérolle JP; Allard J; Allot V; Marquet P; Essig M; Woillard JB
    Eur J Clin Pharmacol; 2020 Jul; 76(7):947-955. PubMed ID: 32358683
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Optimizing gentamicin conventional and extended interval dosing in neonates using Monte Carlo simulation - a retrospective study.
    Bergenwall M; Walker SAN; Elligsen M; Iaboni DC; Findlater C; Seto W; Ng E
    BMC Pediatr; 2019 Sep; 19(1):318. PubMed ID: 31492162
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Population Pharmacokinetics and Dosing Optimization of Gentamicin in Critically Ill Patients Undergoing Continuous Renal Replacement Therapy.
    He S; Cheng Z; Xie F
    Drug Des Devel Ther; 2022; 16():13-22. PubMed ID: 35023902
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Gentamicin in hemodialyzed critical care patients: early dialysis after administration of a high dose should be considered.
    Veinstein A; Venisse N; Badin J; Pinsard M; Robert R; Dupuis A
    Antimicrob Agents Chemother; 2013 Feb; 57(2):977-82. PubMed ID: 23229487
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Optimizing gentamicin dosing in different pediatric age groups using population pharmacokinetics and Monte Carlo simulation.
    Ghoneim RH; Thabit AK; Lashkar MO; Ali AS
    Ital J Pediatr; 2021 Aug; 47(1):167. PubMed ID: 34362436
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Gentamicin pharmacokinetics and dosing in neonates with hypoxic ischemic encephalopathy receiving hypothermia.
    Frymoyer A; Meng L; Bonifacio SL; Verotta D; Guglielmo BJ
    Pharmacotherapy; 2013 Jul; 33(7):718-26. PubMed ID: 23553582
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pharmacokinetics and administration method of gentamicin in a patient on haemodialysis.
    Hiraki Y; Hiraike M; Nagano M; Ozono Y; Manabe K; Misumi N; Tsuji Y; Kamimura H; Karube Y
    Scand J Infect Dis; 2012 Aug; 44(8):630-4. PubMed ID: 22339591
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Bayesian pharmacokinetics of gentamicin in a haemodialysis population.
    Vercaigne LM; Ariano RE; Zacharias JM
    Clin Pharmacokinet; 2004; 43(3):205-10. PubMed ID: 14871157
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Population pharmacokinetics of gentamicin in hospitalized patients receiving once-daily dosing.
    Xuan D; Nicolau DP; Nightingale CH
    Int J Antimicrob Agents; 2004 Mar; 23(3):291-5. PubMed ID: 15164971
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Gentamicin pharmacokinetics and pharmacodynamics during short-daily hemodialysis.
    Decker BS; Mohamed AN; Chambers M; Kraus MA; Moe SM; Sowinski KM
    Am J Nephrol; 2012; 36(2):144-50. PubMed ID: 22813936
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Gentamicin dosing strategy in patients with end-stage renal disease receiving haemodialysis: evaluation using a semi-mechanistic pharmacokinetic/pharmacodynamic model.
    Zhuang L; He Y; Xia H; Liu Y; Sy SK; Derendorf H
    J Antimicrob Chemother; 2016 Apr; 71(4):1012-21. PubMed ID: 26702923
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dosing of gentamicin in patients with end-stage renal disease receiving hemodialysis.
    Teigen MM; Duffull S; Dang L; Johnson DW
    J Clin Pharmacol; 2006 Nov; 46(11):1259-67. PubMed ID: 17050791
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pharmacokinetics of intraperitoneal gentamicin in peritoneal dialysis patients with peritonitis (GIPD study).
    Varghese JM; Roberts JA; Wallis SC; Boots RJ; Healy H; Fassett RG; Lipman J; Ranganathan D
    Clin J Am Soc Nephrol; 2012 Aug; 7(8):1249-56. PubMed ID: 22700884
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Optimizing Gentamicin Dosing in Pediatrics Using Monte Carlo Simulations.
    Alsultan A; Abouelkheir M; Elsharawy Y; Alkoraishi A; Osman R; Neely MN; Mansy W; Algahtani S
    Pediatr Infect Dis J; 2019 Apr; 38(4):390-395. PubMed ID: 30882729
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Temocillin dosing in haemodialysis patients based on population pharmacokinetics of total and unbound concentrations and Monte Carlo simulations.
    Miranda Bastos AC; Vandecasteele SJ; Spinewine A; Tulkens PM; Van Bambeke F
    J Antimicrob Chemother; 2018 Jun; 73(6):1630-1638. PubMed ID: 29579214
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Population pharmacokinetics of ceftriaxone and pharmacodynamic considerations in haemodialysed patients.
    Simon N; Dussol B; Sampol E; Purgus R; Brunet P; Lacarelle B; Berland Y; Bruguerolle B; Urien S
    Clin Pharmacokinet; 2006; 45(5):493-501. PubMed ID: 16640454
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Population Pharmacokinetics of Gentamicin in Neonates with Hypoxemic-Ischemic Encephalopathy Receiving Controlled Hypothermia.
    Cies JJ; Habib T; Bains V; Young M; Menkiti OR
    Pharmacotherapy; 2018 Nov; 38(11):1120-1129. PubMed ID: 30300445
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of two gentamicin dosing schedules in very low birth weight infants.
    Rastogi A; Agarwal G; Pyati S; Pildes RS
    Pediatr Infect Dis J; 2002 Mar; 21(3):234-40. PubMed ID: 12005088
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Population pharmacokinetic modelling, Monte Carlo simulation and semi-mechanistic pharmacodynamic modelling as tools to personalize gentamicin therapy.
    Llanos-Paez CC; Hennig S; Staatz CE
    J Antimicrob Chemother; 2017 Mar; 72(3):639-667. PubMed ID: 28062683
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Population pharmacokinetics and dosing simulations of ceftazidime in critically ill patients receiving sustained low-efficiency dialysis.
    König C; Braune S; Roberts JA; Nierhaus A; Steinmetz OM; Baehr M; Frey OR; Langebrake C; Kluge S
    J Antimicrob Chemother; 2017 May; 72(5):1433-1440. PubMed ID: 28175308
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.